| 1 |
35415233 | Losartan as a Steroid-Sparing Adjunct in a Patient With Features of Refractory Camurati-Engelmann Disease. | 2022 Mar-Apr |
2 |
| 2 |
35446787 | Losartan ameliorates TGF-β1-induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies. | 2022 Jun 1 |
2 |
| 3 |
33475959 | Network Analysis Reveals Proteins Associated with Aortic Dilatation in Mucopolysaccharidoses. | 2021 Mar |
1 |
| 4 |
33532463 | Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion. | 2021 Jan |
2 |
| 5 |
31613648 | Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis. | 2020 Feb 1 |
1 |
| 6 |
30610922 | Losartan attenuates progression of osteoarthritis in the synovial temporomandibular and knee joints of a chondrodysplasia mouse model through inhibition of TGF-β1 signaling pathway. | 2019 Apr |
1 |
| 7 |
31216320 | The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells. | 2019 |
5 |
| 8 |
31385893 | Angiotensin II Type I Receptor Blockade Is Associated with Decreased Cutaneous Scar Formation in a Rat Model. | 2019 Nov |
1 |
| 9 |
30595567 | Downregulation of Profibrotic Gene Expression by Angiotensin Receptor Blockers. | 2018 Nov |
5 |
| 10 |
28849131 | Periostin cross‑reacts with the renin‑angiotensin system during liver fibrosis development. | 2017 Nov |
1 |
| 11 |
28033321 | Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension. | 2016 |
2 |
| 12 |
25342281 | The revised role of TGF-β in aortic aneurysms in Marfan syndrome. | 2015 Feb |
10 |
| 13 |
25655494 | Profibrosing effect of angiotensin converting enzyme inhibitors in human lung fibroblasts. | 2015 Apr |
3 |
| 14 |
24398790 | SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan. | 2014 Aug |
1 |
| 15 |
24632204 | Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK. | 2014 Apr 18 |
2 |
| 16 |
24659129 | Losartan prevents acquired epilepsy via TGF-β signaling suppression. | 2014 Jun |
3 |
| 17 |
24931486 | Pathophysiology and Japanese clinical characteristics in Marfan syndrome. | 2014 Aug |
1 |
| 18 |
25099136 | Positive effects of an angiotensin II type 1 receptor antagonist in Camurati-Engelmann disease: a single case observation. | 2014 Oct |
2 |
| 19 |
23532685 | Angiotensin II Receptor Antagonism Reduces Transforming Growth Factor Beta and Smad Signaling in Thoracic Aortic Aneurysm. | 2013 Spring |
2 |
| 20 |
24084631 | Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. | 2013 |
1 |
| 21 |
21535912 | Losartan enhances the success of myoblast transplantation. | 2012 |
2 |
| 22 |
22372177 | Camurati-Engelmann disease--a rare cause of bone pain. | 2012 Jan |
1 |
| 23 |
21974877 | Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone. | 2011 Oct 6 |
1 |
| 24 |
20067609 | Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial. | 2010 Jan 12 |
1 |
| 25 |
20135646 | Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro. | 2010 Jun 1 |
1 |
| 26 |
20964113 | Marfan syndrome: clinical manifestations, pathophysiology and new outlook on drug therapy. | 2010 Jun |
1 |
| 27 |
19278811 | Urinary TGF-beta1 as an indicator of antiproteinuric response to angiotensin II receptor blocker in proteinuric renal diseases. | 2009 Nov |
1 |
| 28 |
19304546 | [Effects of losartan on left ventricular hypertrophy and plasma transforming growth factor-beta1 in elderly patients with hypertension]. | 2009 Mar |
1 |
| 29 |
19635970 | Circulating transforming growth factor-beta in Marfan syndrome. | 2009 Aug 11 |
1 |
| 30 |
17227571 | Renal allograft protection with angiotensin II type 1 receptor antagonists. | 2007 Jan |
1 |
| 31 |
17301824 | Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients. | 2007 Apr |
1 |
| 32 |
18044261 | A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells. | 2007 Nov |
1 |
| 33 |
16401677 | Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. | 2006 Jun |
2 |
| 34 |
16482098 | Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients. | 2006 Apr |
3 |
| 35 |
16780390 | Different effects of simvastatin and losartan on cytokine levels in coronary artery disease. | 2006 |
2 |
| 36 |
17330452 | Effects of losartan on urinary secretion of extracellular matrix and their modulators in type 2 diabetes mellitus patients with microalbuminuria. | 2006 Dec |
2 |
| 37 |
15770925 | Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. | 2005 Jan-Feb |
1 |
| 38 |
16221098 | TGF-beta and TNF-alpha producing effects of losartan and amlodipine on human mononuclear cell culture. | 2005 Oct |
3 |
| 39 |
16422249 | Effect of losartan on slowing progression of chronic allograft nephropathy. | 2005 Dec |
2 |
| 40 |
12754187 | Angiotensin II and the fibroproliferative response to acute lung injury. | 2004 Jan |
1 |
| 41 |
15349718 | Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy. | 2004 Oct |
2 |
| 42 |
15382153 | Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. | 2004 Nov |
1 |
| 43 |
15470652 | Losartan improves regional left ventricular systolic and diastolic function in patients with hypertension: accurate evaluation using a newly developed color-coded tissue doppler imaging technique. | 2004 Oct |
2 |
| 44 |
15560676 | Inhibition of the effect of high glucose on the expression of Smad in human peritoneal mesothelial cells. | 2004 Oct |
2 |
| 45 |
12748343 | Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy. | 2003 Jun |
2 |
| 46 |
12904684 | Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients. | 2003 Sep-Oct |
2 |
| 47 |
12937228 | Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial. | 2003 Sep |
3 |
| 48 |
14638911 | Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. | 2003 Dec |
1 |
| 49 |
11877567 | Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels. | 2002 Mar |
3 |
| 50 |
12032117 | Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction. | 2002 Jun |
3 |